Deshpande Milind 4
4 · Spero Therapeutics, Inc. · Filed Jan 6, 2020
Insider Transaction Report
Form 4
Deshpande Milind
Director
Transactions
- Award
Stock Option (right to buy)
2020-01-02$6.47/sh+5,408$34,990→ 5,408 totalExercise: $9.87Exp: 2030-01-02→ Common Stock (5,408 underlying)
Footnotes (2)
- [F1]This stock option shall vest in four quarterly installments on the last day of each calendar quarter during the calendar year subject to the Reporting Person's continued service as a non-employee director.
- [F2]This stock option was issued to the Reporting Person, who elected to take stock options in lieu of $35,000 in cash compensation for services as a director, pursuant to the Issuer's non-employee director compensation policy.